These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9122967)

  • 1. Effect of time elapsed since transplantation on lipid and lipoprotein abnormalities in renal transplant patients: role of maintenance prednisone and gender influence.
    Lloveras J; Sentí M; Puig JM; Barbosa F; Oliveras A; Aubó C; Navarro G; Masramon J
    Transplant Proc; 1997; 29(1-2):212-5. PubMed ID: 9122967
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid metabolic abnormalities after renal transplantation under cyclosporine and prednisone immunosuppression.
    Castelao AM; Barberá MJ; Blanco A; Fiol C; Griñó JM; Bover J; GilVernet S; Andrés E; Serón D; Castiñeiras MJ
    Transplant Proc; 1992 Feb; 24(1):96-8. PubMed ID: 1539356
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of serum lipids, lipoproteins, and fibrinogen in patients with kidney transplantation and hemodialysis.
    Demirağ A; Moray G; Ozdemir N; Hizel N; Bilgin N; Haberal M
    Transplant Proc; 1998 Aug; 30(5):2052-3. PubMed ID: 9723389
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormal lipid and lipoprotein profiles following renal transplantation.
    Moore R; Thomas D; Morgan E; Wheeler D; Griffin P; Salaman J; Rees A
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1060-1. PubMed ID: 8442042
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of glucocorticoid-free immunosuppressive protocol on serum lipids in renal transplant patients.
    Nowacka-Cieciura E; Soluch L; Cieciura T; Lewandowska D; Durlik M; Shaibani B; Serafinowicz A; Szmidt J; Rowiński W; Lao M
    Transplant Proc; 2000 Sep; 32(6):1339-43. PubMed ID: 10995973
    [No Abstract]   [Full Text] [Related]  

  • 6. Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients.
    Morrisett JD; Abdel-Fattah G; Kahan BD
    Transplant Proc; 2003 May; 35(3 Suppl):143S-150S. PubMed ID: 12742487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum levels of lipids and lipoproteins in kidney-transplanted patients.
    Mortazavi M; Tohidi M; Rahbani-Nobar M
    Transplant Proc; 2001 Aug; 33(5):2689-90. PubMed ID: 11498125
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal function and lipid metabolism in pregnant renal transplant recipients.
    Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid disturbances in a two-year follow-up after successful kidney transplantation.
    Kisielnicka E; Zdrojewski Z; Wróblewska M; Kortas B; Rutkowski B
    Transplant Proc; 2000 Sep; 32(6):1358-62. PubMed ID: 10995978
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in serum lipid and (APO) lipoprotein levels in renal transplant recipients.
    Ishii T; Imanishi M; Nishioka T; Kunikata S; Akiyama T; Kurita T
    Transplant Proc; 1998 Nov; 30(7):3021-2. PubMed ID: 9838331
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of massive proteinuria following renal transplantation with mycophenolate mofetil and blood pressure normalization.
    Nakache R; Weinbroum A; Merhav H; Katz P; Kaplan E
    Transplant Proc; 2001 May; 33(3):2294-5. PubMed ID: 11377533
    [No Abstract]   [Full Text] [Related]  

  • 12. Sequential analysis of the lipid profile of children post-renal transplantation.
    Singh A; Tejani C; Benfield M; Tejani A
    Pediatr Transplant; 1998 Aug; 2(3):216-23. PubMed ID: 10084746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does pravastatin safely and effectively improve lipid profiles in children who have received a kidney transplant?
    Silverstein DM
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):306-7. PubMed ID: 16932448
    [No Abstract]   [Full Text] [Related]  

  • 14. Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis.
    Busque S; Demers P; St-Louis G; Boily JG; Tousignant J; Lemieux F; Smeesters C; Corman J; Daloze P
    Transplant Proc; 1998 Jun; 30(4):1247-8. PubMed ID: 9636507
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective monitoring of lipid profiles in children receiving pravastatin preemptively after renal transplantation.
    Butani L
    Pediatr Transplant; 2005 Dec; 9(6):746-53. PubMed ID: 16269046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cerivastatin on lipid profiles, lipid peroxidation and platelet and endothelial activation in renal transplant recipients.
    Caillard S; Leray C; Kunz K; Gachet C; Offner M; Wiesel ML; Hannedouchte T; Cazenave JP; Moulin B
    Transplant Proc; 2000 Dec; 32(8):2787-8. PubMed ID: 11134806
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors that influence the incidence and severity of MMF adverse events in renal transplant patients: relationship with corticosteroid dosage, renal function, sex, and patient age.
    Puig JM; Fernández-Crespo P; Lloveras J; Mir M; Iñigo V; Manresa JM; Masramón J
    Transplant Proc; 1999 Sep; 31(6):2270-1. PubMed ID: 10500572
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum lipoproteins in renal transplant patients: the effect of cyclosporine on lipoprotein(a).
    Süleymanlar G; Ozben T; Sapan M; Yìlmaz H; Yakupoglu G; Karpuzoglu T
    Transplant Proc; 1994 Oct; 26(5):2637-8. PubMed ID: 7940822
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study.
    Fernández-Miranda C; de la Calle A; Morales JM; Guijarro C; Aranda JL; Gómez-Sanz R; Gómez-Izquierdo T; Larumbe S; Moreno E; Rodicio JL; del Palacio A
    Clin Transplant; 1998 Apr; 12(2):136-41. PubMed ID: 9575402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients.
    Malyszko J; Malyszko JS; Mysliwiec M
    Transplant Proc; 2009 Oct; 41(8):3056-9. PubMed ID: 19857675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.